HuGE Literature Finder
Records 1-30
|
Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.
Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
|
A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients.
World journal of surgical oncology 2020 Jul 18 (1): 172. Zhang Xilin, Jiang Yan, Yu Huanming, Xia Hui, Wang Xia |
|
Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report.
Journal of cardiothoracic surgery 2020 Jul 15 (1): 196. Yang Yong, Xie Xiaofeng, Jiang Gening, Liu Hongche |
|
Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Clinical lung cancer 2019 Apr . Fan Jun, Dai Xiaofang, Wang Zhenkao, Huang Bo, Shi Heshui, Luo Danju, Zhang Jiwei, Cai Weijing, Nie Xiu, Hirsch Fred |
|
Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer.
Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
|
Identification of a highly lethal V3 TP53 subset in ALK lung adenocarcinoma.
International journal of cancer 2018 Sep . Christopoulos P, Kirchner M, Bozorgmehr F, Endris V, Elsayed M, Budczies J, Ristau J, Penzel R, Herth F J, Heussel C P, Eichhorn M, Muley T, Meister M, Fischer J R, Rieken S, Lasitschka F, Bischoff H, Sotillo R, Schirmacher P, Thomas M, Stenzinger |
|
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
|
Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
Medicine 2018 Jun 97 (26): e11116. Wang Hongyan, Zhang Wen, Wang Kai, Li Xiaofe |
|
Clinicopathological features of younger (aged = 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.
Thoracic cancer 2018 Mar . Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki |
|
[Gene Expression and Clinical Characteristics of Molecular Targeted Therapy ?in Non-small Cell Lung Cancer Patients in Shandong].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Jan 20 (1): 14-20. Qiao Xiuli, Ai Dan, Liang Honglu, Mu Dianbin, Guo Qis |
|
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma.
The Journal of molecular diagnostics : JMD 2017 Jan 19 (1): 169-181. Wang Zheng, Cheng Gang, Han Xiaohong, Mu Xinlin, Zhang Yuhui, Cui Di, Liu Chang, Zhang Li, Fan Zaiwen, Ma Lingyun, Yang Li, Di Jing, Cram David S, Shi Yuankai, Liu Dong |
|
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis
Asian Pacific journal of cancer prevention : APJCP 2017 01 18 (1): 107-114. Tfayli Arafat, Rafei Hind, Mina Alain, Khalil Maya, Fakhreddin Najla, Mahfouz Rami, Hamouri Shadi, Farhat Fadi, Salem Ziad, Dbouk Haifa, Rabee Haider, Saghir Nagi, Shamseddine Ali, Makarem Jawad, Bitar Nizar, Mougharbil Anas, Assi Hazem, Temraz Sally, Mukherji Deborah, Matalka Ismail, Zaatari Gha |
|
The expression of SALL4 is significantly associated with EGFR, but not KRAS or EML4-ALK mutations in lung cancer.
Journal of thoracic disease 2016 Oct 8 (10): 2682-2688. Jia Xiangbo, Qian Rulin, Zhang Binbin, Zhao So |
|
Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China.
Molecular and clinical oncology 2016 May 4 (5): 749-755. Chen Yun, Ye Lijuan, Stanford Rebecca Rongrong, Zhang Dongfang, Zhang Xingsong, Wei Wan |
|
[Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Zhonghua bing li xue za zhi Chinese journal of pathology 2016 Apr 45 (4): 221-5. Chen L F, Chen X Y, Yu X |
|
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr . Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu |
|
[Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].
Revue des maladies respiratoires 2016 Mar . Fournier C, Greillier L, Fina F, Secq V, Nanni-Metellus I, Loundou A, Garcia S, Ouafik L, Tomasini P, Barlesi |
|
Genetic alterations in lung adenocarcinoma with a micropapillary component.
Molecular and clinical oncology 2016 Feb 4 (2): 195-200. Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi |
|
Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population.
Journal of Cancer 2016 7 (15): 2207-2212. Zaric Bojan, Stojsic Vladimir, Panjkovic Milana, Tegeltija Dragana, Stepanov Vanesa, Kovacevic Tomi, Sarcev Tatjana, Radosavljevic Davorin, Milovancev Aleksandar, Adamidis Vasilis, Zarogoulidis Paul, Hohenforst-Schmidt Wolfgang, Trakada Georgia, Rapti Aggeliki, Perin Branisl |
|
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
Journal of translational medicine 2016 06 14 (1): 188. Song Zhengbo, Yu Xinmin, Cheng Guoping, Zhang Yipi |
|
Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
Surgery today 2015 Dec . Ohba Taro, Toyokawa Gouji, Osoegawa Atsushi, Hirai Fumihiko, Yamaguchi Masafumi, Taguchi Ken-Ichi, Seto Takashi, Takenoyama Mitsuhiro, Ichinose Yukito, Sugio Ken |
|
[Mutations of EGFR gene and EML4-ALK fusion gene in superficial lymph node of non-small cell lung cancer].
Zhonghua yi xue za zhi 2015 Jul 95 (26): 2070-3. Wei Lili, Li Xingzhou, Yu Zhong |
|
Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer.
Pathology international 2015 May 65 (5): 231-9. Hsu Sheng-Chi, Hung Tsai-Hsien, Wang Chih-Wei, Ng Kwai-Fong, Chen Tse-Chi |
|
High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 May 10 (5): 778-83. Wu Chunyan, Zhao Chao, Yang Yang, He Yayi, Hou Likun, Li Xuefei, Gao Guanghui, Shi Jingyun, Ren Shengxiang, Chu Haiqing, Zhou Caicun, Zhang Jun, Schmid-Bindert Gera |
|
Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer.
Anticancer research 2015 Mar 35 (3): 1791-6. Morodomi Yosuke, Okamoto Tatsuro, Kohno Mikihiro, Katsura Masakazu, Takada Kazuki, Suzuki Yuzo, Fujishita Takatoshi, Kitahara Hirokazu, Shimamatsu Shinichiro, Yoshida Tsukihisa, Tagawa Tetsuzo, Okano Shinji, Maehara Yoshihi |
|
EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Lung cancer (Amsterdam, Netherlands) 2015 Mar 87 (3): 272-7. Yang Yong, Yang Yang, Zhou Xiao, Song Xiao, Liu Ming, He Wenxin, Wang Hao, Wu Chunyan, Fei Ke, Jiang Geni |
|
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.
OncoTargets and therapy 2015 8 117-23. Doval Dc, Prabhash K, Patil S, Chaturvedi H, Goswami C, Vaid Ak, Desai S, Dutt S, Veldore Vh, Jambhekar N, Mehta A, Hazarika D, Azam S, Gawande S, Gupta |
|
Clinical characteristics of patients with non-small cell lung cancers harboring anaplastic lymphoma kinase rearrangements and primary lung adenocarcinoma harboring epidermal growth factor receptor mutations.
Genetics and molecular research : GMR 2015 14 (4): 12973-83. Xu L, Lei J, Wang Q Z, Li J, Wu |
|
Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger.
PloS one 2015 10 (9): e0136659. Wang Yuehong, Chen Junjun, Ding Wei, Yan Bing, Gao Qiqi, Zhou Jianyi |
|
Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan.
PloS one 2015 10 (3): e0120852. Hsu Kuo-Hsuan, Ho Chao-Chi, Hsia Te-Chun, Tseng Jeng-Sen, Su Kang-Yi, Wu Ming-Fang, Chiu Kuo-Liang, Yang Tsung-Ying, Chen Kun-Chieh, Ooi Hean, Wu Tzu-Chin, Chen Hung-Jen, Chen Hsuan-Yu, Chang Chi-Sheng, Hsu Chung-Ping, Hsia Jiun-Yi, Chuang Cheng-Yen, Lin Chin-Hung, Chen Jeremy J W, Chen Kuan-Yu, Liao Wei-Yu, Shih Jin-Yuan, Yu Sung-Liang, Yu Chong-Jen, Yang Pan-Chyr, Chang Gee-Ch |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 16, 2021
- Content source: